Dermata Therapeutics Warrant
DRMAW
5 hedge funds and large institutions have $16.4K invested in Dermata Therapeutics Warrant in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
0.56% less ownership
Funds ownership: 2.37% → 1.81% (-0.56%)
17% less capital invested
Capital invested by funds: $19.7K → $16.4K (-$3.32K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$135 |
| 2 |
AC
Armistice Capital
New York
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $16.2K | – | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $138 | +$135 | +12,857 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $46 | -$1 | -100 | -2% |
|
|
AC
4
Armistice Capital
New York
| $14 | +$14 | +1,354 | New |
|
5
Bank of America
Charlotte,
North Carolina
| $1 | – | – | – |
|
DRMAW Hedge Fund Activity: Q4 2024 in Review
5 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Dermata Therapeutics Warrant (DRMAW) for Q4 2024, worth a combined $16.4K — down 17% from $19.7K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new DRMAW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $135. The largest seller was UBS Group, cutting an estimated $1.
- 5 institutional investors held Dermata Therapeutics Warrant (DRMAW) as of Q4 2024, up from 3 in Q3 2024.
- Funds reported $16.4K of Dermata Therapeutics Warrant stock for Q4 2024, down 17% quarter-over-quarter.
- 2 funds opened new Dermata Therapeutics Warrant positions in Q4 2024 and 0 closed out, a net change of +2 holders.
- The largest Dermata Therapeutics Warrant buyer in Q4 2024 was Two Sigma Securities, an estimated $135 added.
- The largest Dermata Therapeutics Warrant seller in Q4 2024 was UBS Group, an estimated $1 sold.
Based on aggregated 13F filings for Q4 2024.